Acute Skin Toxicity Following Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer: Who's at Risk?

Article ID	Journal	Published Year	Pages	File Type
8236732	International Journal of Radiation OncologyBiologyPhysics	2008	4 Pages	PDF

Abstract

SBRT can be associated with significant skin toxicity. One must consider the skin dose when evaluating the treatment plan and consider the bolus effect of immobilization devices.

Keywords

Lung cancer Skin toxicity image-guided radiation therapy stereotactic body radiation therapy intensity-modulated radiation therapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Acute Skin Toxicity Following Stereotactic Body Radiation Therapy for Stage I Non-Small-Cell Lung Cancer: Who's at Risk?

Authors

Bradford S. M.D., Benjamin M.D., Alex V. B.A., Sandra C. B.A., Elizabeth R.N., Ellen D. Ph.D., D. Michael Ph.D., Margie A. M.S., Kenneth E. M.D.,